Yuan Chang and Patrick Moore, researchers at the University of Pittsburgh Cancer Institute, have been awarded the 2017 Paul Ehrlich and Ludwig Darmstaedter Prize.
The European Society for Medical Oncology announced the creation of a new award honoring individuals for achievements in cancer immunotherapy. The award will be presented at ESMO's newly launched Immuno-Oncology Congress in Geneva this December.
Jupiter Medical Center said it will adopt IBM's Watson for Oncology trained by Memorial Sloan Kettering Cancer Center, which will go live at the beginning of March.
The joint program of Fox Chase Cancer Center and Temple University Hospital earned accreditation by the Foundation for the Accreditation of Cellular Therapy at the University of Nebraska Medical Center for adult allogeneic and autologous hematopoietic progenitor cell transplantation, peripheral blood cellular therapy product collection, and cellular therapy product processing with minimal manipulation.
Data and technology platform Cota and Hackensack Meridian Health in New Jersey have partnered to help improve clinical and cost outcomes for cancer patients.
The National Comprehensive Cancer Network said it has published a Guidelines for Patients and NCCN Quick Guide sheet for Waldenström's Macroglobulinemia—a rare, but manageable type of Non-Hodgkin's Lymphoma.
Keith Flaherty was named editor inchief of Clinical Cancer Research, one of eight peer-reviewed journals published by the American Association for Cancer Research.
Stephen Gottschalk was named chair of the Department of Bone Marrow Transplantation and Cellular Therapy at St. Jude Children's Research Hospital.
Denis Guttridge was named associate director for basic research at The Ohio State Comprehensive Cancer Center.
Elisabeth Heath, of the Barbara Ann Karmanos Cancer Institute and Wayne State University School of Medicine, was named associate center director for transitional sciences.
